Information:
Fel:
ID
34047
Beskrivning
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson`s Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02224664
Länk
https://clinicaltrials.gov/show/NCT02224664
Nyckelord
Versioner (1)
- 2019-01-12 2019-01-12 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
12 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Parkinson`s Disease NCT02224664
Eligibility Parkinson`s Disease NCT02224664
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson`s Disease NCT02224664
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Parkinson Disease | Characteristics Main Quantity | Tremor | Rigidity | Bradykinesia
Item
clinical diagnosis of idiopathic parkinson's disease with at least 2 out of 3 cardinal characteristics (tremor, rigidity, bradykinesia)
boolean
C0030567 (UMLS CUI [1])
C1521970 (UMLS CUI [2,1])
C1542147 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0040822 (UMLS CUI [3])
C0026837 (UMLS CUI [4])
C0233565 (UMLS CUI [5])
C1521970 (UMLS CUI [2,1])
C1542147 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0040822 (UMLS CUI [3])
C0026837 (UMLS CUI [4])
C0233565 (UMLS CUI [5])
Mini-mental state examination
Item
mini-mental state examination (mmse) ≥ 25
boolean
C0451306 (UMLS CUI [1])
Hoehn and Yahr Stage
Item
hoehn & yahr stage i-iii inclusive
boolean
C3639483 (UMLS CUI [1])
End Levodopa Wearing off
Item
documented history of end of l-dopa wearing off
boolean
C2746065 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
C1504539 (UMLS CUI [1,3])
C0023570 (UMLS CUI [1,2])
C1504539 (UMLS CUI [1,3])
Dyskinesia Following Levodopa Dosage | MDS-UPDRS - Functional Impact of Dyskinesias
Item
cohort 5 only: history of dyskinesia following l-dopa dosing and score of at least 2 on part iv, item 4.2 (functional impact of dyskinesia) of the mds-updrs
boolean
C0013384 (UMLS CUI [1,1])
C0332282 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,4])
C3639485 (UMLS CUI [2])
C0332282 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,4])
C3639485 (UMLS CUI [2])
Atypical Parkinsonism | Secondary Parkinson Disease
Item
atypical/secondary parkinsonism
boolean
C4302185 (UMLS CUI [1])
C0030569 (UMLS CUI [2])
C0030569 (UMLS CUI [2])
Surgical intervention Parkinson Disease
Item
history of surgical intervention for parkinson's disease
boolean
C0549433 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,2])
Dementia Interferes with Clinical Trial Assessment | Impaired cognition Interferes with Clinical Trial Assessment
Item
dementia/cognitive impairment that can interfere with study assessments
boolean
C0497327 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1516048 (UMLS CUI [1,4])
C0338656 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C1516048 (UMLS CUI [2,4])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1516048 (UMLS CUI [1,4])
C0338656 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C1516048 (UMLS CUI [2,4])